← Back to Search

Bone Conduction Hearing Aid

Osia 2 System for Conductive Hearing Loss

N/A
Waitlist Available
Led By Mark Syms, MD
Research Sponsored by Cochlear
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months post-surgery
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at whether the Osia 2 system, which is a device meant to help people with conductive or mixed conductive hearing loss, is effective in a group of US patients.

Eligible Conditions
  • Mixed Hearing Loss
  • Conductive Hearing Loss

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months post-surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months post-surgery for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change From Baseline in Adaptive Speech in Noise Test Score for Osia 2 System at 3 Months Post-surgery
Secondary study objectives
Number of Device or Procedure Related Adverse Events

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Osia 2 SystemExperimental Treatment1 Intervention
Osia 2 Active Osseointegrated Implant System for Bone Conduction
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Osia 2 System
2022
N/A
~70

Find a Location

Who is running the clinical trial?

CochlearLead Sponsor
93 Previous Clinical Trials
6,144 Total Patients Enrolled
Mark Syms, MDPrincipal InvestigatorArizona Hearing Center
~4 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top